A Study to Develop Additional Safety and Clinical Experience With NATRECOR hBNP (Nesiritide) in the Treatment of Patients With Worsening Congestive Heart Failure Who Require Inpatient Intravenous Therapy With Medications That Influence the Tone and Caliber of Blood Vessels
This study has been completed.
Sponsor:
Scios, Inc.
Information provided by:
Scios, Inc.
ClinicalTrials.gov Identifier:
NCT00271557
First received: December 30, 2005
Last updated: March 3, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 1997 |
| Estimated Primary Completion Date: | No date given |